Poland· PL-100437834
Icatibant Zentiva
A icatibant product containing icatibantum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Icatibant is registered in 15 of 19 countries.
Countries holding a registration under ATC B06AC02 (icatibant), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Icatibant · ATC B06AC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Icatibantum
- Manufacturer
- Zentiva, k.s.
- Country
- Poland (PL)
- ATC code
- B06AC02
- ATC class
- Icatibant
- Defined daily dose
- 30 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991469290
- gtin05909991469306
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
10 interactions on record for icatibant.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Icatibant · interactions on record
10 records
- 10 moderate
Most severe, free to view
- CaptoprilC09AA01moderate
- EnalaprilC09AA02moderate
- LisinoprilC09AA03moderate
- PerindoprilC09AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Icatibant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenFirazyr 30 mg Injektionsvätska, lösning i förfylld sprutaTakeda Pharmaceuticals International AG Ireland Branch
- SpainFIRAZYR 30 mg SOLUCION INYECTABLE EN JERINGA PRECARGADATakeda Pharmaceuticals International Ag Ireland Branch
- CzechiaFIRAZYRTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- BelgiumFirazyr 30 mgTakeda Pharmaceuticals International Ireland Branch
- IcelandFirazyrTakeda Pharmaceuticals International AG Ireland Branch
- NorwayIcatibant Medical ValleyMedical Valley Invest AB
- GermanyIcatibant AguettantLaboratoire Aguettant
- FinlandFirazyrTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Icatibant Hikma, Icatibant Ratiopharm®
- Belgium · Icatibant Hikma Farmacêutica (Portugal) S.A., Icatibant Teva
- Bulgaria · Icatibant Sandoz
- Czechia · Icatibant Fresenius, Icatibant Universal Farma
- Germany · Icatibant Aliud Pharma Gmbh, Icatibant Amarox
- Denmark · Icatibant "viatris", Icatibant Adalvo
- Estonia · Icatibant Auxilia, Icatibant Fresenius
- Spain · Icatibanto Cipla, Icatibanto Exeltis
- Finland · Icatibant Avansor, Icatibant Glenmark
- France · Icatibant Amarox, Icatibant Fresenius
- United Kingdom (Northern Ireland) · Icatibant Amarox, Icatibant Fresenius Kabi Limited
- Croatia · Ikatibant Alpha-Medical, Ikatibant Fresenius
- Hungary · Icatibant Fresenius, Icatibant Stada
- Iceland · Firazyr, Icatibant Accord
- Italy · Icatibant, Icatibant Amarox
- Liechtenstein · Firazyr, Icatibant Accord
- Lithuania · Icatibant Fresenius, Idanuz
- Latvia · Idanuz
- Malta · Icatibant Newbury, Idisan
- Netherlands · Icatibant Ethypharm, Icatibant Glenmark
- Norway · Firazyr, Icatibant
- Portugal · Icatibant Fresenius, Icatibant Hikma Farmacêutica (Portugal) S.A.
- Romania · Icatibant Stada, Icatibant Universal Farma
- Sweden · Icatibant Avansor, Icatibant Glenmark
- Slovakia · Icatibant Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4c33806-1e72-43dc-b656-b20e30b8dcc2 GET /v1/drugs/e4c33806-1e72-43dc-b656-b20e30b8dcc2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "30 mg",
"packaging": "05909991469290 ¦ Rp ¦ 142427\n3 amp.-strzyk. 3 ml\n05909991469306 ¦ Rp ¦ 142428\n1 amp.-strzyk. 3 ml",
"substance": "Icatibanti acetas 30 31,38-35,52 mg/3,0 ml",
"common_name": "Icatibantum",
"pl_product_id": "100437834",
"pozwolenie_nr": "26718",
"auth_procedure": "DCP",
"authorisation_validity": "2026-07-27"
}See everything about icatibant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.